Alsuma Alternatives Compared
Alsuma | Ubrelvy | Atogepant |
|
---|
Alsuma (sumatriptan) | Ubrelvy (ubrogepant) | Atogepant |
|
|||||||
---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Cluster Headaches, Migraine. Alsuma may also be used for purposes not listed in this medication guide. |
Prescription only
Ubrelvy may be used to treat acute migraine attacks in adults and works by blocking the effects of a protein, called CGRP that is thought to play a role in migraine attacks by causing pain, dilation... View more |
Prescription only
Prescribed for Chronic Migraine, Migraine Prevention, Headache, Migraine. atogepant may also be used for purposes not listed in this medication guide. |
Related suggestions Migraine
|
|||||||
More about Alsuma (sumatriptan) | More about Ubrelvy (ubrogepant) | More about Atogepant | ||||||||
Ratings & Reviews | ||||||||||
Alsuma has an average rating of 10.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Ubrelvy has an average rating of 6.1 out of 10 from a total of 238 ratings on Drugs.com. 55% of reviewers reported a positive effect, while 39% reported a negative effect. |
Atogepant has an average rating of 7.8 out of 10 from a total of 129 ratings on Drugs.com. 68% of reviewers reported a positive effect, while 10% reported a negative effect. |
||||||||
Drug Class | ||||||||||
Side Effects | ||||||||||
See also: Alsuma side effects in more detail. |
See also: Ubrelvy side effects in more detail. |
See also: atogepant side effects in more detail. |
||||||||
Generic Availability | ||||||||||
Lower cost generic approved |
N/A |
|||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Ubrelvy prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Form(s) Available | ||||||||||
|
|
N/A |
||||||||
Brand Names | ||||||||||
Other sumatriptan brands include: Imitrex, Imitrex Nasal, Imitrex Statdose, Onzetra Xsail, Tosymra, Zembrace SymTouch |
N/A |
Qulipta | ||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||
6 hours |
7 hours |
11 hours |
||||||||
CSA Schedule ** View glossary of terms | ||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | ||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
Drug Interactions | ||||||||||
A total of 99 drugs are known to interact with Alsuma:
|
A total of 218 drugs are known to interact with Ubrelvy:
|
A total of 177 drugs are known to interact with atogepant:
|
||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Disease Interactions | ||||||||||
First Approval Date | ||||||||||
N/A |
December 23, 2019 |
September 28, 2021 |
||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||
N/A |
N/A |
N/A |
||||||||
More Information | ||||||||||
Patient resources | ||||||||||
Professional Resources | ||||||||||
N/A |
||||||||||
Related Treatment Guide | ||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.